Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
The legendary actor said he helped a woman who was giving birth under a tree in London's Richmond Park.
Jordan Burndred's devastated mum Nicola confirmed the news on Facebook saying the 17-year-old 'didn't make it through the night.'
At least four plots attempts to smuggle highly-radioactive materials to Islamic State militants were stopped in the last five years.